-
Bayer $1.3 Billion Collaboration Agreement
Bayer
Bayer and Kumquat Biosciences announce a $1.3 billion global collaboration to develop and commercialize a KRAS G12D inhibitor, aiming to offer new treatment options for pancreatic, colorectal, and lung cancer patients.
碌曲县|
丹东市|
遂宁市|
应城市|
定南县|
无极县|
嘉禾县|
怀来县|
郁南县|
河东区|
长寿区|
永嘉县|
宁陕县|
鸡东县|
玉龙|
文登市|
克拉玛依市|
敦煌市|
景德镇市|
涞源县|
余江县|
大埔县|
西贡区|
芮城县|
蕉岭县|
通海县|
元氏县|
定边县|
聂拉木县|
湖南省|
南江县|
湘西|
确山县|
蕉岭县|
阿坝县|
沐川县|
黔西县|
牟定县|
隆尧县|
神池县|
吉木乃县|